Risk of Recurrence After Treatment for Cervical Intraepithelial Neoplasia 3 and Adenocarcinoma In Situ of the Cervix: Recurrence of CIN 3 and AIS of Cervix.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The aim of the study was to evaluate recurrence risk of cervical intraepithelial neoplasia (CIN) 3+ and adenocarcinoma in situ (AIS)+ in a large population cohort of women previously treated for CIN 3/AIS.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): J Low Genit Tract Dis

Title: Journal of lower genital tract disease

Publisher: Ovid Technologies (Wolters Kluwer Health)

ISSN (Electronic): 1526-0976

ISSN (Print): 1089-2591

Publication date (Electronic): Jul 2020

Volume: 24

Issue: 3

Affiliations

[1 ] Department of Obstetrics and Gynaecology, University of Toronto, Toronto, Ontario, Canada.

[2 ] Cancer Care Ontario, Toronto, Ontario, Canada.

[3 ] Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.

Article

DOI: 10.1097/LGT.0000000000000542

PubMed ID: 32384365

SO-VID: f0d31141-32b6-49dd-95c0-9dbb85c9ae00

History

Data availability:

Comments

Comment on this article

scite_

Cited by 2

See all cited by